Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sexually Transmitted Infections01:26

Sexually Transmitted Infections

289
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
289
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Social determinants of health screening and referral services in community pharmacies: A payor program analysis.

Journal of the American Pharmacists Association : JAPhA·2026
Same author

Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers.

Research and practice in thrombosis and haemostasis·2026
Same author

"Let's Talk Stigma": A Pharmacy-Based Program for Opioid Use Disorder Anti-Stigma Education in Pennsylvania.

Pharmacy (Basel, Switzerland)·2026
Same author

Preparing Future Pharmacists to Identify and Address Intimate Partner Violence (IPV) in Pharmacy Practice.

American journal of pharmaceutical education·2025
Same author

Development of a community-focused emergency response tool for medication-related preparedness.

Journal of the American Pharmacists Association : JAPhA·2025
Same author

Implementation strategies for the provision of fentanyl test strips in community pharmacies: Perspectives from pharmacy teams and harm reduction experts.

Journal of the American Pharmacists Association : JAPhA·2025

Related Experiment Video

Updated: Jun 15, 2025

Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

12.8K

Community pharmacy chlamydia and gonorrhea test-to-treat program: Development of an implementation toolkit.

Joni C Carroll, Thai Q Nguyen, Jordan Ciraolo

    Journal of the American Pharmacists Association : Japha
    |August 26, 2024
    PubMed
    Summary

    Community pharmacies can now offer chlamydia and gonorrhea testing and treatment. A new toolkit provides resources to help pharmacies implement these vital sexual health services, addressing rising sexually transmitted infection rates.

    More Related Videos

    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
    08:04

    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

    Published on: February 8, 2019

    8.6K
    Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
    10:32

    Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

    Published on: June 10, 2020

    4.2K

    Related Experiment Videos

    Last Updated: Jun 15, 2025

    Forward Genetic Approaches in Chlamydia trachomatis
    09:03

    Forward Genetic Approaches in Chlamydia trachomatis

    Published on: October 23, 2013

    12.8K
    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
    08:04

    Quantitative Examination of Antibiotic Susceptibility of Neisseria gonorrhoeae Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

    Published on: February 8, 2019

    8.6K
    Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
    10:32

    Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

    Published on: June 10, 2020

    4.2K

    Area of Science:

    • Public Health
    • Pharmacy Practice
    • Infectious Diseases

    Background:

    • Over 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported nationally in the US in 2022.
    • Community pharmacies are accessible points for nonemergency medical care, positioning them to address rising sexually transmitted infection (STI) rates.
    • A pilot program in Pennsylvania developed a test-to-treat service for chlamydia and gonorrhea within a community pharmacy setting.

    Purpose of the Study:

    • To develop an expert-informed implementation toolkit for pharmacy-based chlamydia and gonorrhea test-to-treat programs.
    • To create a resource to assist other entities in establishing similar pharmacy-based STI screening and treatment services.

    Main Methods:

    • The toolkit outline was based on the University of California at Berkeley's "How to Build an Implementation Toolkit from Start to Finish" framework.
    • Content was developed through a literature review, pilot program team meetings, and expert feedback.
    • The draft toolkit underwent review by external experts and potential end-users.

    Main Results:

    • An 11-item toolkit was created, including resources such as STI training materials, standing orders for testing and treatment, screening forms, marketing strategies, patient education, and workflow examples.
    • The toolkit was reviewed by 11 external experts and potential end-users.
    • Key resources were identified to support pharmacy teams in implementing STI services.

    Conclusions:

    • Pharmacies may require additional resources to effectively implement STI testing and treatment programs.
    • The developed toolkit can help pharmacies overcome barriers to implementing chlamydia and gonorrhea test-to-treat services.
    • This initiative supports the expansion of pharmacy-based STI screening and treatment to combat rising infection rates.